This grant opportunity from the FDA aims to support the development of therapeutics for ultra-rare cancers. The funding opportunity number is FOR-FD-26-004 and the CFDA number is 93.103.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Research and Development Services for Ultra-Rare Cancer Therapeutics
1
project
$1,000,000.00
$1,000,000.00
Professional Services
Estimated Bid Value
$1,000,000.00
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.